Status:
COMPLETED
Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor
Lead Sponsor:
Medical University of Lublin
Conditions:
Ovarian Cancer
Borderline Ovarian Tumors
Eligibility:
FEMALE
18-75 years
Brief Summary
The aim of the study was to estimate the percentage and of Treg, Th17 and NKT in peripheral blood and the tissue of the epithelial ovarian tumor and relationship with blood serum level of HE4, CA125, ...
Detailed Description
Study groups. The study group consisted of 60 women. The patients were divided into 3 subgroups: a group of 24 women with malignant epithelial ovarian tumors (cystadenocarcinomas), 25 women with benig...
Eligibility Criteria
Inclusion
- written informed consent
- age 18-75
- ovarian tumor
Exclusion
- below 18 years old
- necrosis in tumor
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03779399
Start Date
December 1 2011
End Date
December 31 2016
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IInd Department of Gynecology
Lublin, Poland, 20-954